Lebanon vs Malaysia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Lebanon
0.1%
in 2024
Malaysia
0.1%
in 2024
Lebanon rank
134th
Malaysia rank
134th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Lebanon
- Malaysia
How they compare
Lebanon currently reports 0.1% against 0.1% in Malaysia, a difference of 0.0%.
Across all 10 years both countries report, Malaysia has been ahead every year.
Lebanon ranks 134th and Malaysia ranks 134th of 246 countries.
Malaysia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.2% | 0.2% | Malaysia |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Lebanon or Malaysia?
- Lebanon, at 0.1% against 0.1% in Malaysia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Lebanon and Malaysia?
- 0.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Malaysia?
- 10 years are reported by both, from 2015 to 2024.
- How do Lebanon and Malaysia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Lebanon ranks 134th and Malaysia ranks 134th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.